类他类药物的增生效应:关注炎症,氧化应激和免疫调节 (第一部分)
Ali Mahmoudi1, Niki Katsiki2,3, Michal Vrablik4
1Department of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran.
Current atherosclerosis reports
|January 10, 2026
概括
通过抗炎和抗氧化作用,他类药除了降低胆固醇之外,还提供心血管保护. 了解这些热性机制可以揭示预防心血管疾病的新策略.
科学领域:
- 心血管药理学心血管药理学
- 类药物效应 药物效应 药物效应
- 免疫调节是一种免疫调节.
背景情况:
- 由于降脂效应,他类药物是预防心血管疾病 (CVD) 的主要药物.
- 新出现的证据突出表明,他类药物通过独立于胆固醇调节的类机制发挥心脏保护作用.
研究的目的:
- 审查他类药物的性作用,重点关注抗炎,抗氧化和免疫调节作用.
- 讨论这些影响对心血管结果的临床相关性.
主要方法:
- 在主要数据库 (Embase,Scopus,Web of Science,PubMed,Cochrane Library) 中进行全面的文献搜索.
- 包括实验和临床研究,调查他类药物对炎症,氧化应激和免疫功能的影响.
主要成果:
- 类药物表现出显著的抗炎,抗氧化和免疫调节活性.
- 这些类效应有助于心血管保护,独立于降低胆固醇.
- 类药物改善内皮功能,稳定斑块,并表现出抗血栓性质.
结论:
- 类药物通过多种类途径提供心脏保护.
- 进一步的研究应该优化他类药物治疗方案,并探索其与脂质无关的治疗潜力.
- 彻底了解他类药物的性特征可以导致新的预防策略和心血管疾病的治疗方法.
更多相关视频
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
14.0K
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.7K
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Inflammation
61.5K
Overview
61.5K
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
Atherosclerosis I: Introduction
868
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
868
